A randomized, observer-blind, vehicle-control, multi-center clinical investigation for assessing the efficacy and tolerability of a 1% ectoine and hyaluronic acid 0.1%-containing medical device in pediatric patients with mild-to-moderate atopic dermatitis,Pediatric Dermatology

当前位置： X-MOL 学术 › Pediatr. Dermatol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A randomized, observer-blind, vehicle-control, multi-center clinical investigation for assessing the efficacy and tolerability of a 1% ectoine and hyaluronic acid 0.1%-containing medical device in pediatric patients with mild-to-moderate atopic dermatitis
Pediatric Dermatology ( IF 1.5 ) Pub Date : 2022-08-29 , DOI: 10.1111/pde.15117
Alex Alexopoulos ₁ , Maria Dakoutrou ₁ , Lamprini Nasi ₁ , Ioanna Thanopoulou ₁ , Talia Kakourou ₁ , Louiza Kontara ₂ , Nikolaos Douladiris ₃ , Maria Galani ₃ , Paraskevi Xepapadaki ₃ , Chrysoula Doxani ₄ , Theodoros Mprotsis ₄ , Elias Zintzaras _{4,

5} , Nikolaos G Papadopoulos ₃ , Christina Kanaka-Gantenbein ₆ , George P Chrousos _{6,

7}

Affiliation

Ectoine is a widespread osmolyte enabling halophilic bacteria to withstand high osmotic stress that has many potential applications ranging from cosmetics to its use as a therapeutic agent.

中文翻译：